Your browser doesn't support javascript.
loading
Soluble ACE2 and angiotensin II levels are modulated in hypertensive COVID-19 patients treated with different antihypertension drugs.
A Elrayess, Mohamed; T Zedan, Hadeel; A Alattar, Rand; Abusriwil, Hatem; Al-Ruweidi, Mahmoud Khatib A A; Almuraikhy, Shamma; Parengal, Jabeed; Alhariri, Bassem; Yassine, Hadi M; A Hssain, Ali; Nair, Arun; Al Samawi, Musaed; Abdelmajid, Alaaeldin; Al Suwaidi, Jassim; Omar Saad, Mohamed; Al-Maslamani, Muna; Omrani, Ali S; Yalcin, Huseyin C.
Afiliación
  • A Elrayess M; Biomedical Research Center, Qatar University, Doha, Qatar.
  • T Zedan H; Biomedical Research Center, Qatar University, Doha, Qatar.
  • A Alattar R; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
  • Abusriwil H; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
  • Al-Ruweidi MKAA; Department of Internal Medicine, Hazm Mebaireek General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Almuraikhy S; Biomedical Research Center, Qatar University, Doha, Qatar.
  • Parengal J; Biomedical Research Center, Qatar University, Doha, Qatar.
  • Alhariri B; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
  • Yassine HM; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
  • A Hssain A; Department of Internal Medicine, Hazm Mebaireek General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Nair A; Biomedical Research Center, Qatar University, Doha, Qatar.
  • Al Samawi M; Medical Intensive Care Unit, Hamad Medical Corporation, Doha, Qatar.
  • Abdelmajid A; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
  • Al Suwaidi J; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Omar Saad M; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
  • Al-Maslamani M; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Omrani AS; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
  • Yalcin HC; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Blood Press ; 31(1): 80-90, 2022 12.
Article en En | MEDLINE | ID: mdl-35548940
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Hipertensión Límite: Humans Idioma: En Revista: Blood Press Asunto de la revista: ANGIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Qatar
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Hipertensión Límite: Humans Idioma: En Revista: Blood Press Asunto de la revista: ANGIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Qatar